Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

ICON’s novel RNA-based NGS assay, Dup-Seq BCR::ABL1, represents a significant advancement in the management of CML patients.

More than $994 million has been raised by Cambridge technology companies in the past 12 months (to October 16, 2024) – helped ...

Your daily dose of what's up in emerging technology Founded at the Massachusetts Institute of Technology in 1899, MIT Technology Review is a world-renowned, independent media company whose insight ...

Their work can help to lower the ... The Evolution of Green Energy Technology: Developing Three-Dimensional Smart Energy Devices With Radiant Cooling and Solar Absorption Oct. 25, 2024 — - DGIST ...

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia (APL) and chronic myeloid leukemia (CML) in patient samples. Researchers at Dana-Farber Cancer ...

The S&P/ASX 200 Information Technology sector fell 4.43% in October but leads ASX sectors YTD, up 41.95% Global X investment ...

Novartis has received FDA accelerated approval for Scemblix (asciminib) to treat adults with newly diagnosed Ph+ CML-CP.

In the case of CML, a disease in which patients have too many immature white blood cells in their bone marrow and blood, a complete hematologic response occurs when the patient's white blood cell ...

The goal of this internal strategy is to define how the United Nations system will support the use of new technologies like artificial intelligence, biotechnology, blockchain, and robotics to ...

Today the battle over standards is between China and the West. At stake is the future of technologies ranging from wireless communication to quantum computing and artificial intelligence (AI).

Developed by Ascentage Pharma, olverembatinib is the first China -approved third-generation BCR:ABL1 inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent ...